• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al.

作者信息

Srinivasan Krithika, Ho Dora Y

机构信息

Division of Infectious Diseases & Geographic Medicine, School of Medicine, Stanford University, Stanford, California, USA.

出版信息

Antimicrob Agents Chemother. 2023 May 17;67(5):e0027623. doi: 10.1128/aac.00276-23. Epub 2023 Apr 4.

DOI:10.1128/aac.00276-23
PMID:37014226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10190666/
Abstract
摘要

相似文献

1
Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al.病例评论：博塞蒂等人所著的《普瑞替韦用于异基因造血细胞移植受者难治性单纯疱疹病毒口腔病变的挽救治疗》
Antimicrob Agents Chemother. 2023 May 17;67(5):e0027623. doi: 10.1128/aac.00276-23. Epub 2023 Apr 4.
2
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients.异基因造血细胞移植受者普瑞巴林治疗难治性单纯疱疹病毒口腔病变。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0173222. doi: 10.1128/aac.01732-22. Epub 2023 Mar 27.
3
Management of Refractory/Resistant Herpes Simplex Virus Infections in Haematopoietic Stem Cell Transplantation Recipients: A Literature Review.造血干细胞移植受者难治性/耐药单纯疱疹病毒感染的管理：文献复习。
Rev Med Virol. 2024 Sep;34(5):e2574. doi: 10.1002/rmv.2574.
4
Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.阿昔洛韦治疗异基因造血干细胞移植受者中对阿昔洛韦耐药或难治的单纯疱疹病毒感染：两例病例报告。
Int J Antimicrob Agents. 2024 Jun;63(6):107169. doi: 10.1016/j.ijantimicag.2024.107169. Epub 2024 Apr 10.
5
Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.异基因干细胞移植受者中阿昔洛韦耐药单纯疱疹病毒感染的抗病毒治疗延迟和不良结局-一项回顾性研究。
Transpl Int. 2018 Jun;31(6):639-648. doi: 10.1111/tri.13142. Epub 2018 Mar 13.
6
Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.异基因造血干细胞移植并进行T细胞去除后早期出现的耐阿昔洛韦单纯疱疹病毒1型感染
J Infect Chemother. 2017 Jul;23(7):485-487. doi: 10.1016/j.jiac.2017.02.001. Epub 2017 Mar 2.
7
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.接受异基因造血干细胞移植患者中由耐阿昔洛韦单纯疱疹病毒引起的感染
Pathol Biol (Paris). 2001 Sep;49(7):553-8. doi: 10.1016/s0369-8114(01)00205-x.
8
Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2.普瑞巴林治疗阿昔洛韦耐药性单纯疱疹病毒 2 型。
Int J STD AIDS. 2021 Sep;32(10):978-980. doi: 10.1177/09564624211006568. Epub 2021 May 4.
9
Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.造血细胞移植患者应用高剂量阿昔洛韦持续输注治疗阿昔洛韦耐药单纯疱疹病毒。
Biol Blood Marrow Transplant. 2011 Feb;17(2):259-64. doi: 10.1016/j.bbmt.2010.06.020. Epub 2010 Jul 6.
10
Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.在一名异基因造血干细胞移植患者中，局部使用西多福韦成功清除皮肤阿昔洛韦耐药、膦甲酸钠难治性疱疹病毒病变。
J Oncol Pharm Pract. 2013 Jun;19(2):181-5. doi: 10.1177/1078155212448408. Epub 2012 May 25.

本文引用的文献

1
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients.异基因造血细胞移植受者普瑞巴林治疗难治性单纯疱疹病毒口腔病变。
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0173222. doi: 10.1128/aac.01732-22. Epub 2023 Mar 27.
2
Resistant herpes simplex virus infections - who, when, and what's new?耐疱疹单纯病毒感染 - 谁、何时以及有何新进展？
Curr Opin Infect Dis. 2022 Dec 1;35(6):530-535. doi: 10.1097/QCO.0000000000000889. Epub 2022 Oct 7.
3
Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.普瑞巴林的发现、化学结构和临床前开发：一种治疗阿昔洛韦耐药单纯疱疹病毒感染的新选择。
J Med Chem. 2022 Oct 27;65(20):13614-13628. doi: 10.1021/acs.jmedchem.2c00668. Epub 2022 Oct 6.
4
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.阿昔洛韦，一种解旋酶-引物酶抑制剂，用于带状疱疹的最佳治疗。
Viruses. 2021 Aug 5;13(8):1547. doi: 10.3390/v13081547.
5
Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.普瑞巴林和阿昔洛韦治疗单纯疱疹脑炎小鼠模型单纯疱疹病毒感染的疗效。
Antiviral Res. 2018 Jan;149:1-6. doi: 10.1016/j.antiviral.2017.11.002. Epub 2017 Nov 4.
6
Helicase-primase inhibitor pritelivir for HSV-2 infection.普瑞巴林治疗单纯疱疹病毒 2 型感染的临床研究进展
N Engl J Med. 2014 Jan 16;370(3):201-10. doi: 10.1056/NEJMoa1301150.